MS
IBB icon

Maven Securities’s iShares Biotechnology ETF IBB Stock Holding History

Maven Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-107,000
Closed -$12.6M – 1157
2022
Q2 		$12.6M Buy
+107,000
New +$12.7M 0.38% 46

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Maven Securities's IBB Position: Q3 2025 in Review

Maven Securities sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 6,014 shares — an estimated $761K sold.

Maven Securities first reported a position in IBB in Q1 2020 and held it in 8 quarters. The position peaked at $3.66M in Q2 2022. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Maven Securities reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 6,014 iShares Biotechnology ETF shares in Q3 2025, an estimated $761K.
  • Maven Securities first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 8 quarters.
  • Maven Securities's iShares Biotechnology ETF position peaked at $3.66M in Q2 2022.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.